MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Massachusetts General Hospital Evaluation of DePuy ASR Hip System

Conditions: Osteoarthritis

First Posted Date: 2012-06-04

Last Posted Date: 2021-01-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1950

Registration Number: NCT01611233

Locations: 🇺🇸
Texas Hip and Knee Center, Fort Worth, Texas, United States
🇦🇺
Sportsmed Sa, Stepney, South Australia, Australia
🇿🇦
Morningside Medi-Clinic, Bryanston, South Africa

and more 10 locations

A Modernized Approach to Prenatal Care in Low Risk Women

Not Applicable

Completed

Conditions: Pre-eclampsia
Intrauterine Growth Retardation

Interventions: Other: Modernized prenatal care

First Posted Date: 2012-05-28

Last Posted Date: 2017-02-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4

Registration Number: NCT01606774

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury

Phase 1

Withdrawn

Conditions: Subdural Hematoma
Head Injury
Cerebral Edema
Traumatic Brain Injury
Cerebral Contusion

Interventions: Drug: Standard of care (hypertonic saline and mannitol; serum sodium)
Drug: Induced, sustained hypernatremia using hypertonic saline

First Posted Date: 2012-05-24

Last Posted Date: 2016-12-12

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT01605357

Building on a Point-of-purchase Intervention to Encourage Healthy Food Choices

Not Applicable

Completed

Conditions: Food Labeling

Interventions: Behavioral: Feedback plus incentives
Behavioral: Feedback letters

First Posted Date: 2012-05-23

Last Posted Date: 2015-10-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 2672

Registration Number: NCT01604499

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

11C Acetate Imaging Post Prostatectomy

Not Applicable

Terminated

Conditions: Prostate Cancer

Interventions: Other: 11C Acetate Imaging

First Posted Date: 2012-05-21

Last Posted Date: 2014-03-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 2

Registration Number: NCT01602783

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix

Not Applicable

Completed

Conditions: Cervical Cancer
Uterine Cancer

Interventions: Radiation: Proton radiation therapy

First Posted Date: 2012-05-16

Last Posted Date: 2024-10-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 22

Registration Number: NCT01600040

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Understanding "Heparin Resistance" in Cardiac Surgery

Phase 1

Completed

Conditions: Cardiopulmonary Bypass
Altered Heparin Response

Interventions: Drug: Heparin
Drug: ATryn

First Posted Date: 2012-05-15

Last Posted Date: 2016-12-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 504

Registration Number: NCT01598883

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Natural History of Hopelessness, Suicidality, and Optimism in Psychiatric Inpatients Following Discharge

Completed

Conditions: Suicidal Ideation
Suicide, Attempted

First Posted Date: 2012-05-15

Last Posted Date: 2014-08-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 46

Registration Number: NCT01599247

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

International HIV Antiretroviral Adherence, Resistance and Survival

Completed

Conditions: HIV/AIDS

First Posted Date: 2012-05-11

Last Posted Date: 2017-10-31

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 750

Registration Number: NCT01596322

Locations: 🇺🇬
Mbarara ISS Clinic, Mulago HIV Clinic, Mbarara, Uganda

Brentuximab Vedotin for Steroid Refractory GvHD

Phase 1

Completed

Conditions: Graft vs. Host Disease

Interventions: Drug: Brentuximab Vedotin

First Posted Date: 2012-05-10

Last Posted Date: 2018-07-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT01596218

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy